Skip to main content
Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.850
-0.100 (-5.13%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Gain Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
78.15M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 202355.18K-77.46K-58.40%
Dec 31, 2022132.64K-1.29K-0.96%
Dec 31, 2021133.93K--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Champions Oncology 57.95M
Gossamer Bio 48.47M
Sangamo Therapeutics 39.55M
Alterity Therapeutics 4.43M
NeurAxis 3.57M
eXoZymes -700.00
Revenue Rankings

GANX News

More News